Business Context and Reporting Period
This Form 8-K reports on events occurring at the 2026 Annual Meeting of Stockholders for Agios Pharmaceuticals, Inc., held on June 18, 2026. The filing details corporate governance actions, including the election of directors, executive compensation votes, and amendments to equity incentive plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting results rather than financial performance.
Material Changes and Voting Results
Director Elections (Class I)
Stockholders elected three Class I directors to three-year terms expiring in 2029:
- Rahul Ballal, Ph.D.: 40,145,081 votes For; 5,943,999 votes Withheld.
- Brian Goff: 45,757,238 votes For; 331,843 votes Withheld.
- Cynthia Smith: 31,496,376 votes For; 14,592,704 votes Withheld.
Executive Compensation
Stockholders approved the non-binding advisory vote on executive compensation with 43,396,045 votes For and 1,086,059 votes Against.
Stock Incentive Plan Amendment
Stockholders approved the "2023 Plan Amendment," which increases the number of shares available for issuance under the 2023 Stock Incentive Plan by 2,000,000 shares. This increase also applies to shares available for issuance as incentive stock options. The vote resulted in 43,549,751 votes For and 2,527,678 votes Against.
Independent Auditor Ratification
Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year. The vote was 48,511,213 For and 116,938 Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the Annual Meeting votes.
Investor Verification Checklist
- Verify the impact of the 2,000,000 share increase on potential future dilution.
- Review the full text of the amended 2023 Stock Incentive Plan (Exhibit 99.1) for specific terms.
- Monitor the tenure of the newly elected Class I directors (Rahul Ballal, Brian Goff, Cynthia Smith) through 2029.
- Confirm the continued engagement of PricewaterhouseCoopers LLP for the upcoming fiscal year.